Advertisements

Гаскон Дроп

Quick links to important sections

Гаскон Дроп

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Гаскон Дроп

Property Description
Active ingredient Dimethicone (Polydimethylsiloxane)
Form Oral Liquid Drops (Дроп)
Pharmacological class Antifoaming Agent, Carminative
Common use Relief of gas and bloating symptoms
Origin Synthetic Polymer

What Type of Preparation is Гаскон Дроп?

Гаскон Дроп is an oral pharmaceutical preparation classified as both an antifoaming agent and a carminative, designed specifically for local physical action within the digestive tract. The medicinal entity is supplied as an oral liquid in a drop form (Дроп), which facilitates its oral route of administration. This preparation is non-systemic, meaning the active substance is not absorbed into the body’s circulation, a property that minimizes systemic interaction. The pharmacological class is defined by this function, addressing the management of gas discomfort by physical means rather than chemical or biological processes.

Composition: The Role of Dimethicone

The sole active ingredient in Гаскон Дроп is Dimethicone, which is chemically defined as Polydimethylsiloxane (PDMS). Dimethicone is a defined, synthetic polymer belonging to the silicone group of compounds. This single-ingredient preparation is suspended in an aqueous or oily vehicle suitable for oral consumption. The role of silicone-based anti-flatulence agents like Dimethicone relates to the management of excess intestinal gas. This inert polymer is almost entirely eliminated from the body unchanged, further defining its non-systemic identity.

General Purpose of this Carminative Agent

The general purpose of this specific antifoaming agent is the relief of pressure and bloating associated with excess gastrointestinal gas and flatulence. The action is physical: Dimethicone reduces the surface tension of small gas bubbles entrapped in the digestive contents. By facilitating the coalescence of these bubbles into larger gas pockets, the preparation enables the body’s natural physiological processes to eliminate the accumulated gas more easily, thereby achieving the general therapeutic benefit of restoring gastrointestinal comfort.

Advertisements

What side effects are possible with Гаскон Дроп?

Possible Side Effects and Safety Information

The official safety profile of Гаскон Дроп (Dimethicone) is defined by its non-systemic action; the active ingredient is not absorbed into the body's circulation. Adverse reactions are primarily limited to the gastrointestinal tract and allergic responses, as documented in official government regulatory sources.


Adverse Reactions and Frequency

Adverse effects are grouped into specific System Organ Classes (SOCs) for regulatory communication:

  • Gastrointestinal Disorders: These may include non-specific gastrointestinal discomfort, nausea, or, rarely, diarrhea. Due to the reliance on post-marketing spontaneous reporting for this class of non-prescription drug, the frequency of these mild events is often officially classified as Not Known.
  • Immune System and Skin Disorders: These classes document the potential for hypersensitivity reactions to Dimethicone or the preparation’s excipients, which may manifest as rash or pruritus (itching).

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions officially listed in regulatory labeling are those related to hypersensitivity, which are classified as Rare or Very Rare. These include severe allergic manifestations such as angioedema (swelling of the face or throat).

Safety constraints and limitations are primarily focused on two areas:

  • Contraindication: The preparation must not be used in individuals with a known hypersensitivity to any component of the drops.
  • Intestinal Pathology: Official labeling advises against use in the presence of known or suspected intestinal obstruction.

Safety for pediatric use (infants and children) is considered established in regulatory documents due to the non-toxic, non-absorbed nature of the active ingredient. No specific warnings for renal or hepatic impairment are mandated in regulatory labels, consistent with the drug’s lack of systemic absorption.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Гаскон Дроп (Dimethicone) overdose is defined by the substance's inert, non-systemic properties. The active ingredient is a polymer that is not absorbed into the body's circulation, which leads to a negligible risk of acute systemic toxicity even if excessive quantities are ingested. Systemic effects, such as cardiovascular or central nervous system complications, are not anticipated and are not documented in official prescribing information.

Documented Overdose Presentations Overdose manifestations are expected to be confined entirely to the gastrointestinal tract. Symptoms that may be observed following the ingestion of an excessive amount are limited to local effects such as temporary abdominal discomfort or abdominal fullness. Regulatory assessments consistently state that no specific signs of acute systemic toxicity have been reported.

Emergency Action and Required Management Regulatory authorities require that an individual seek immediate medical attention or contact a poison control center for any suspected ingestion of a large, excessive quantity. This action is mandated as a general precaution. The official management intervention is restricted to symptomatic and supportive treatment for local discomfort. Furthermore, no specific antidote is known or available for this substance. Clinical observation or monitoring may be required in a hospital setting, depending on the volume of the liquid drops ingested.

Advertisements

Therapeutic Uses of Гаскон Дроп

What Гаскон Дроп Treats: Main Uses and Benefits

The use of Гаскон Дроп (Dimethicone/Simethicone) is focused entirely on providing symptomatic relief for acute and recurrent issues stemming from excess gas in the digestive tract. It is applied in contexts where additional symptomatic support is needed to help improve comfort and stability.

Such preparations are typically utilized to help with symptoms related to physical discomfort caused by excess gas.


Managing Acute Abdominal Pressure and Fullness

This preparation is commonly used across conditions characterized by episodic or fluctuating symptom patterns of gastrointestinal distension. It helps address symptom clusters such as the feeling of bloating, tightness, and generalized pressure in the abdomen. This supports the management of symptoms that interfere with daily functioning, providing relief that assists patients with symptom fluctuations during episodes of gas buildup.


Easing Gas-Related Discomfort and Pain

The primary therapeutic benefit is applied in contexts where short-term, supportive relief is needed for gas-related pain and discomfort. Used when symptoms create noticeable physiological strain, the medication contributes to improved day-to-day comfort during periods of heightened symptoms. This is considered relevant for the discomfort arising from general flatulence and the fussiness and distress often observed in infants due to trapped wind.


Supportive Use in Clinical Scenarios

Гаскон Дроп is also relevant in clinical settings that involve acute or unstable symptom patterns, such as managing post-operative gas retention or aiding in the preparation for certain diagnostic procedures like endoscopy. Applied in scenarios where additional management of discomfort is required, it supports the preparation for examination by reducing gas and foam, assisting the process of visualization or post-operative comfort.

Quick Fact: Relief for Symptoms related to Physical Discomfort

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Гаскон Дроп? Official Regulatory Information

The eligibility profile for Гаскон Дроп (Dimethicone/Simethicone) is defined by official regulatory documents, primarily restricting use based on ingredient sensitivity or severe pre-existing gastrointestinal conditions.


Populations Excluded from Use

Contraindication Description
Hypersensitivity Individuals with a known allergy or sensitivity to Dimethicone/Simethicone or any of the inactive ingredients are strictly contraindicated (must not use).
Gastrointestinal Obstruction Use is contraindicated in patients with known or suspected intestinal obstruction (bowel blockage) or perforation of the digestive tract.

Approved and Permitted Populations

Regulatory agencies confirm eligibility across a wide range of patients due to the medicine's non-systemic action (it is not absorbed into the body):

  • Age-Group Eligibility: The liquid drop formulation is officially approved for use in the pediatric population, including infants from birth onwards, as well as adolescents and adults.
  • Pregnancy and Lactation: Use is permitted during both pregnancy and breastfeeding.
  • Organ Impairment: Patients with hepatic (liver) or renal (kidney) impairment are permitted to use the medicine, as no specific dose adjustment is necessary.

The official eligibility criteria are highly restrictive concerning the absolute ban, but broadly permissive for otherwise healthy individuals across all age groups and physiological states.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Field Official Regulatory Information for Dimethicone
Medicinal product categories with documented interactions Oral Thyroid Hormone Preparations (e.g., Levothyroxine, Liothyronine).
Specific interacting medicines (if explicitly listed) Levothyroxine (L-Thyroxine).
Mechanistic basis of interactions Pharmacokinetic interaction of the absorption type, where Dimethicone physically interferes with the gastrointestinal absorption of the co-administered drug, resulting in decreased oral bioavailability.
Timing-based interaction rules Mandatory separation of administration: Regulatory documents require co-administered Oral Thyroid Hormone Preparations and Dimethicone to be taken at least 4 hours apart.
Population-specific interaction notes None documented.
Interaction-related restrictions Restriction on co-administration timing; absolute contraindications are not specified for this interaction.

Resulting Interaction Structure

Regulatory documents define the interaction profile of Гаскон Дроп by focusing exclusively on a single absorption-based pharmacokinetic interaction. Due to the non-systemic nature of Dimethicone, interactions involving CYP enzymes, drug transporters, or systemic pharmacodynamic effects are not listed in official prescribing information.

This profile is structured around the risk of reduced systemic exposure of co-administered essential medicines, such as thyroid hormones, and the resulting regulatory requirement for a strict timing separation protocol to ensure effective absorption of the second drug.

Advertisements

Mechanism of Action

Physicochemical Mechanism: Destabilizing Gas-Liquid Interfaces

The mechanism of Гаскон Дроп (Dimethicone) is entirely physical and non-systemic, acting as a surfactant within the gastrointestinal lumen. It engages the physicochemical domain by drastically reducing the surface tension of the stabilizing film that encapsulates numerous small, trapped gas bubbles in digestive contents. This interaction does not involve classical biological targets (receptors or enzymes) but instead targets the physical boundary between gas and liquid.


Mechanistic Cascade: Coalescence and Enhanced Gas Mobility

The primary physiological consequence of reduced surface tension is the initiation of a rapid mechanistic cascade: the small, unstable gas bubbles immediately coalesce (merge) into fewer, significantly larger gas pockets. This transformation disrupts the foam barrier and allows for the liberation of the gas. The resulting increase in gas size and mobility facilitates the intrinsic physiological mechanisms for expulsion, promoting gas elimination via eructation and flatulence.

Advertisements

Dosage and Administration Information

The Гаскон Дроп oral liquid suspension is administered by the oral route and is typically used for as-needed administration, rather than continuous treatment. To ensure proper administration of the antifoaming agent, the suspension must be shaken well before use. The dose must be accurately measured using the dedicated dropper or syringe provided with the product, as ordinary kitchen utensils do not offer the required volumetric precision. The medicine is typically taken after meals and at bedtime when symptoms arise.

Dosing regimens are stratified by age. For adults and adolescents 12 years and older, the dose ranges from 40 mg to 125 mg per administration. Children between 2 and 12 years receive a dose of 40 mg (0.6 mL), while infants under 2 years are given 20 mg (0.3 mL) per dose.

Administration frequency is limited to up to four times daily. Adherence to the maximum daily limit is required, which for adults must not exceed 500 mg in any 24-hour period. Due to the compound’s non-systemic nature, dosing protocols do not specify dose adjustments for hepatic or renal impairment.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Гаскон Дроп


Evidence for use in Reducing Excess Gas and Bloating

Гаскон Дроп was studied for its use in populations with symptoms related to trapped air and excess gas in the digestive system. Research examined how this product was associated with outcomes related to physical discomfort, such as bloating and flatulence, in individuals presenting with these issues. The studies focused on exploring how symptoms change over time in conditions characterized by fluctuating or episodic manifestations.

Findings describe patterns observed in the studies, which contributes to understanding symptom patterns, particularly outcomes related to systemic or functional imbalance. However, evidence quality varies across studies, and research does not determine whether an individual will respond similarly.

Evidence for use in Preparing for Diagnostic Procedures

Гаскон Дроп was also evaluated in research settings for its role in preparing patients for certain types of internal diagnostic procedures, such as gastroscopy or abdominal X-rays. Studies monitored its effect in research exploring short-term symptom changes and outcomes related to systemic or functional imbalance.

Research describes its use in settings where an objective is to facilitate visualization during the procedure. This evidence contributes to the broader evidence landscape for the product's specific, non-symptomatic applications. However, the results apply only to the populations studied, and sample sizes were modest in some of these technical studies.


Long-term studies and follow-up

Research has explored what happens when Гаскон Дроп was observed in studies over extended periods. Follow-up durations were limited in most published research, meaning long-term effects are not fully established. Evidence so far provides insight into short-term changes, but there is limited information for long-term outcomes and outcomes reflecting the durability of response.

Evidence in special populations

Specific studies were observed in or examined certain patient groups, including children, older adults, or those with existing comorbid conditions. For some groups, such as children, evidence is considered in research exploring short-term symptom changes. However, data for certain groups, such as those with specific comorbid conditions or pregnancy-related populations, remain insufficient, and evidence is limited.

What is still uncertain about Гаскон Дроп

This final section synthesizes the areas where research is still needed or where current findings are not definitive. Comparative evidence is lacking to fully understand how Гаскон Дроп relates to other available options. Data are still emerging regarding the factors that might influence findings describing patterns observed in the studies. Because evidence quality varies across studies, the research provides context but not individual predictions about a personal outcome.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Гаскон Дроп (FAQ)


Q: How quickly does Гаскон Дроп start working?

A: Official information describes the mechanism of the active ingredient as a physical anti-foaming process that occurs directly within the digestive tract. Because the product does not need to be absorbed into the bloodstream (it is non-systemic), this rapid physical process is associated with symptom relief that may begin relatively quickly after taking the dose.


Q: Can I take Гаскон Дроп if I have stomach pain that isn't gas?

A: Regulatory documents indicate the product is intended specifically for the relief of symptoms caused by trapped gas, such as bloating and pressure. The product is indicated for symptoms specifically caused by trapped gas. Its role is defined by its anti-foaming action. Official labeling also contraindicates use if there is a known or suspected severe condition, such as intestinal obstruction.


Q: Can Гаскон Дроп be used alongside antacids?

A: Regulatory documents do not list antacids as a specific contraindication. The active ingredient in Гаскон Дроп is also commonly found in commercial products that combine it with antacid ingredients. Because the active ingredient is available in products that combine it with antacids, co-administration is a documented use pattern.


Q: Can I use Гаскон Дроп if I'm taking vitamins or supplements?

A: Official regulatory warnings focus on a specific, rare absorption-type interaction with oral thyroid hormone preparations. Due to the product's non-systemic nature, regulatory sources do not list specific interactions with general vitamins or mineral supplements.


Q: Why is it important to shake the bottle of Гаскон Дроп before use?

A: Official administration instructions state that the liquid suspension must be shaken well prior to each use. The active ingredient can settle over time, and this step is required to re-disperse the settled active ingredient throughout the liquid, which helps maintain the intended concentration in the dose.


Q: Does Гаскон Дроп cause any changes in bowel movements?

A: Official safety information documents the potential for minor adverse effects, which are primarily related to the gastrointestinal tract. Regulatory sources list general gastrointestinal discomfort and, in rare cases, diarrhea as possible adverse reactions associated with the product's use.


Q: What is the consensus in medical literature regarding the general use of the active substance in Гаскон Дроп?

A: Research evidence, as summarized in government-related medical resources, describes patterns observed in studies regarding relief from gas symptoms. The product is also studied for specific applications, such as facilitating visibility during certain diagnostic procedures. Evidence quality varies across studies, and research does not determine whether an individual will respond similarly.


Q: Does Гаскон Дроп help with severe bloating?

A: The regulatory labels indicate the product is intended for the relief of symptoms including bloating, pressure, and fullness. The medicine's mechanism is designed to address the presence of excess gas, regardless of the perceived severity of the resulting symptoms.


Q: Do you need a prescription for Гаскон Дроп?

A: Regulatory documents classify the active ingredient in this product as an Over-The-Counter (OTC) medicine in most regions, meaning it is available for purchase without requiring a prescription from a healthcare professional.


Q: Is it normal to feel no effect after the first time taking Гаскон Дроп?

A: Official patient guidance acknowledges the possibility of a non-response. If symptoms of gas and bloating do not start to improve or if they get worse after use, professional advice may be sought for further evaluation.


Q: Are there any specific foods or drinks to avoid when using Гаскон Дроп?

A: There are no specific mandatory food or drink interactions listed in the regulatory warnings for this product. However, official resources suggest that individuals may consider limiting carbonated beverages and certain foods that cause gas, though this is not listed as a mandatory interaction or warning for the medicine itself.


Q: Has Гаскон Дроп been studied in people with irritable bowel syndrome (IBS)?

A: Clinical literature summarized in government resources confirms that the active ingredient has been investigated for use in individuals with Irritable Bowel Syndrome (IBS) and other functional gastrointestinal disorders. These studies typically focus on managing the gas-related symptoms associated with these conditions.


Q: Does Гаскон Дроп contain sugar, alcohol, or other common additives?

A: Regulatory labels provide a complete list of inactive ingredients, which can vary by manufacturer and specific formulation. These ingredients may include compounds like Sucrose (sugar), Sorbitol, or Dextrose. Some products are officially labelled as 'Alcohol free'.


Q: Is it possible to become dependent on Гаскон Дроп if used regularly?

A: Official sources describe the active ingredient as being a physiologically inert polymer that is not absorbed into the bloodstream. Because the active ingredient acts physically and is not absorbed into the body, the mechanism of action does not involve chemical interactions that lead to dependence. Official documentation does not report a potential for pharmacological dependence.


Q: What should I do if I forget to take a scheduled amount of Гаскон Дроп?

A: Official instructions indicate this product is for as-needed (PRN) use, meaning the concept of a 'missed dose' does not typically apply. The medicine may be taken when symptoms are present, within the limits of the official maximum daily frequency.


Q: Does Гаскон Дроп have an effect on stomach acid?

A: The active ingredient itself is an anti-foaming agent that acts physically on gas bubbles and does not have a direct effect on stomach acid. However, the active ingredient is often combined with antacid compounds (which do neutralize stomach acid) in many commercially available preparations.


Q: Can older adults use Гаскон Дроп safely?

A: Official regulatory documents confirm that the medicine is permitted for use across the entire adult population, including older adults. The non-systemic mechanism of action means no specific warnings or dose adjustments are mandated based on advanced age alone.


Q: Is the drop form of Гаскон Дроп better for certain people?

A: Official regulatory documents confirm that the liquid drop formulation is approved for use in the pediatric population, including infants. This form is specifically noted for its suitability in administering the measured dose to young children.


Q: Can Гаскон Дроп be mixed with liquids other than water?

A: Official administration directions for the drops formulation state that the dose may be mixed with 1 ounce of cool water to facilitate swallowing. Additionally, it can be mixed with infant formula or other suitable liquids when administered to children.


Q: Are there different strengths or concentrations of Гаскон Дроп available?

A: Regulatory documents confirm that products containing the active ingredient are available in multiple dosage strengths for oral use, such as different milligram quantities in tablets or different concentrations in the liquid drop formulation.


Q: Does Гаскон Дроп have any known effect on liver or kidney function?

A: Due to the medicine's non-systemic nature—meaning it is not absorbed into the body—it does not pass through the liver (hepatic metabolism). Official documents state that no specific warnings or dose adjustments are mandated for patients with existing liver or kidney impairment.


Q: Is there any clinical evidence supporting the use of Гаскон Дроп for infantile colic?

A: Clinical literature summarized in government resources confirms that the active ingredient has been studied for use in infants with colic. However, this area of research has produced mixed findings across different published studies.


Q: Can someone who is lactose intolerant use Гаскон Дроп?

A: The list of inactive ingredients for the drop formulation is generally free of lactose. Excipient composition can vary by product and manufacturer, but most regulatory labels for the drops do not list lactose as a component, making it likely suitable for individuals with lactose intolerance.


Q: Does Гаскон Дроп expire, and how should I check the date?

A: Like all pharmaceutical products, Гаскон Дроп does expire. Official documentation requires that the specific expiration date is clearly marked on the outer packaging and on the container label. Outdated product should be discarded according to local pharmaceutical waste regulations.


Q: Is the effect of Гаскон Дроп temporary, or does it offer long-term relief?

A: Official regulatory literature describes the product's use for the relief of acute, episodic gas and bloating symptoms. The mechanism is physical and non-systemic, resulting in a temporary effect that addresses the gas present at the time of administration, rather than providing long-term prevention or cure.


Q: What if a small child accidentally takes too much Гаскон Дроп?

A: Official warnings state that if an accidental ingestion of a quantity higher than recommended occurs, medical help or contact with a Poison Control Center is warranted. Official warnings strongly advise keeping the product Out of Reach of Children.


Q: Does Гаскон Дроп affect the results of any medical tests?

A: Official research and guidelines confirm that the product is sometimes used to deliberately improve visualization during internal diagnostic procedures, such as colonoscopy and endoscopy, by reducing the presence of gas bubbles in the digestive tract.


Q: Does Гаскон Дроп have a flavor, and is it artificial?

A: The list of inactive ingredients on regulatory labels often includes flavoring agents (such as 'Peppermint Flavor') to make the liquid palatable. Depending on the specific manufacturer, the product may be officially labelled as containing 'No artificial flavor' or 'Natural flavor'.


Q: Is it mandatory to speak to a healthcare professional before starting Гаскон Дроп?

A: Since the product is an Over-The-Counter (OTC) medicine, a prescription is not required. However, regulatory labels indicate that it may be necessary to consult a healthcare professional before use, particularly for individuals who are pregnant, breastfeeding, or have certain existing medical conditions.


Q: What is the official definition of the symptoms Гаскон Дроп is intended for?

A: The symptoms officially listed on the regulatory drug facts label are the relief of pressure, bloating, and fullness. These three symptoms are consistently used in official documentation to describe the gas discomfort the product is intended to treat.


Q: What happens if you take Гаскон Дроп and the gas doesn't go away?

A: Official guidance states that if symptoms of gas and bloating do not start to improve or if they become more severe, professional clinical advice may be sought. This includes if accompanying symptoms like severe pain, diarrhea, or blood in the stool are present.

Advertisements

How should Гаскон Дроп be stored and disposed of?

Storage and Disposal Requirements for Гаскон Дроп

Official regulatory documentation outlines specific requirements for storing and disposing of Гаскон Дроп (Dimethicone oral liquid suspension) to maintain its quality and ensure safety.

Storage Conditions

The medicine must be stored below 30 C and kept from freezing, which can physically destabilize the liquid formulation. The container must be stored away from direct sunlight, excess heat, and moisture. It is required that the product be kept in its original receptacle with the cap tightly closed to prevent contamination or evaporation. The product must always be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Do not keep outdated or unused medicine. The unused product must be discarded according to local pharmaceutical waste regulations. Regulatory guidance instructs users to consult a pharmacist or medical institution for the proper procedure on how to discard the expired or no longer needed product, and to avoid allowing the product to reach sewage systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Гаскон Дроп found in:

A-Z Index: